Answers are grounded in this paper and cite their sources.
Evaluates cough response in guinea pigs with allergic rhinitis, indicating nav1.8 as a target.
BACKGROUND: 1.8 inhibitor A-803467 attenuates this response. METHODS: OVA challenge. Tested animals were pretreated with aerosolized A-803467 (3mM) or vehicle for 10min prior to and during citric acid exposure. RESULTS: weeks of OVA challenge, without affecting respiratory rate. CONCLUSION: 1.8 as a potential therapeutic target for cough associated with allergic airway inflammation.
No takes yet. Share an insight, caveat, or question.
Brozmanová et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: